Ashoka Buildcon

The Toll Booth That Sold Its Toll Booths

Picture a family that owns a busy toll bridge. For years they collect coins from every car that crosses. Then one day they decide to sell the bridge itself to a bigger operator, and a huge lump sum lands in their bank account. Their bank balance looks spectacular that year — but next year there are no more coins from that bridge. That, in plain terms, is Ashoka Buildcon right now, and understanding this single fact is the whole ballgame.

Ashoka builds roads, highways and bridges — some on straight contract (EPC, they get paid to build and walk away) and some on the toll-collection model (BOT, they build, own and collect for years). It also sells ready-mix concrete and switchgear on the side. A steady, unglamorous infrastructure outfit that has been laying tarmac across India for decades.

Why The Cheapness Is Real And Also A Mirage

The number that pulls a value investor's eye is the P/E of 4.29. Against Ashoka's own five-year median of 15.8, that is roughly a *73% discount*; against the ten-year median of 13.3, about a *68% discount*. The stock also trades at 0.52 times book — you are being offered a rupee of stated net worth for around fifty-two paise. On the surface, this is the kind of gap that makes one lean forward.

Now the asterisk, and it is a large one. That reported profit of ₹1,734 crore last year and the ₹2,576 crore figure this year include roughly **₹2,327 crore of *other income*** — largely the fruit of Ashoka selling down its road assets, exactly like our family selling the bridge. Strip that away and the operating business is far more ordinary. So the "4.29 P/E" is not four times *recurring* earnings; it is four times a number swollen by one-time monetisation. A P/E is only as honest as the E beneath it, and here the E is wearing a costume.

The Operating Engine, Read Plainly

Look past the accounting fireworks and the picture is mixed. Sales grew a compounded 9% over five years and 10% over ten — respectable but hardly thrilling, and Screener rightly flags it as poor for a company of this vintage. Worse, the trend has turned: three-year sales growth is *minus 2%*, and the trailing year shows revenue falling from around ₹10,037 crore to ₹7,520 crore, a 25% drop. The order book is clearly working through a lean patch. Return on capital employed at 26.5% is genuinely good, but ROE has slipped from a three-year average near 29% down to 15.3% last year — the toll booths that generated those fat returns are the very ones being sold.

One thing I like without reservation: there has been no dilution. Equity capital sat at ₹140 crore from March 2019 right through to today, unchanged for seven years. Before that it was smaller still. Management has grown this business without repeatedly reaching into shareholders' pockets — a discipline I never take for granted. Set against that, the working-capital story is deteriorating: debtor days have stretched from 54 to 78, working-capital days have ballooned from 30 to 142, and the cost of borrowing is described as high. Cash is getting stuck in the pipes.

And despite years of repeated profits, the company pays no dividend at all. For a firm supposedly harvesting asset sales, returning nothing to owners is a legitimate grumble.

How To Hold This, And For How Long

This is a *Short Term Strategy* entry — a one-to-six-month idea, not a decade-long marriage. The logic is straightforward: a stock down 39% over the past year, sitting at half its book value and near its 52-week low of ₹101 against a high of ₹214, where the asset monetisation genuinely fattens near-term book and provides a cushion. The setup is a beaten-down infrastructure name with a real balance-sheet event that the market has punished alongside the falling revenue. Promoters have held firm at 54.5%, and FIIs and the public have been quietly adding while domestic institutions trimmed.

I want to be blunt, in the Omaha way. The bargain optics — 4.29 P/E, 0.52 book — are seductive precisely because they are partly manufactured by non-recurring gains. Do not mistake this for a compounder you tuck away and forget. Treat it as what it is: a cheap, out-of-favour builder with a temporary earnings sugar-rush, held on a short leash. Buy with a horizon measured in weeks and months, keep a firm exit in mind, and respect that the falling sales, stretched receivables and absent dividend are telling you the operating story is soft even as the headline profit dazzles. Cheapness is a margin of safety only when you know exactly what you are paying for — here, you are paying for a discount that is real, wrapped around earnings that are not entirely repeatable.